Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

multiple endocrine adenomatosis type 2B

(MUL-tih-pul EN-doh-krin A-deh-NOH-muh-TOH-sis ...)
A rare, genetic disorder that affects the endocrine glands and causes a type of thyroid cancer called medullary thyroid cancer, pheochromocytoma, and parathyroid gland cancer. It may also cause benign (noncancerous) tumors in the adrenal glands and growths around the nerves in the lips, tongue, lining of the mouth, and eyelids. Gastrointestinal symptoms and trouble with the spine or bones in the feet and thighs may also occur. Multiple endocrine adenomatosis type 2B is caused by a mutation (change) in a gene called RET. Also called MEN2B, MEN2B syndrome, and multiple endocrine neoplasia type 2B syndrome.
Search NCI's Dictionary of Cancer Terms